Description
Anticonvulsant and antiepileptic drug. The active component of the drug – pregabalin – inhibits the movement of calcium into neuron cells in response to the action potential. The substance is characterized by a high degree of affinity for alpha-2-delta protein located in the tissues of the central nervous system. The use of the drug leads to a decrease in the release of pain neurotransmitters into the synaptic cleft when neurons are excited. Due to such changes, the impulse is selectively suppressed under the influence of the drug. But only in pathological conditions does Lyric have such an effect. Lyrica have the properties of an analgesic for pain of non-neuropathic and postoperative origin.
Does not provoke cancer. The drug is well absorbed and begins to act within an hour after administration. The drug is best taken on an empty stomach, since the concentration of the drug in plasma while taking it with food is significantly reduced.
Withdrawal of the drug is carried out with urine.
Elderly people and those suffering from impaired renal function require dose adjustment of the drug.
INDICATIONS
neuropathic pain. The drug Lyric is prescribed for treatment of neuropathic pain in adults with damage to the peripheral and central nervous system.
Epilepsy. The drug Lyric is prescribed as adjunctive therapy for partial convulsive seizures with or without secondary generalization in adults.
Generalized Anxiety Disorder. The drug Lyric is prescribed for treatment of generalized anxiety disorder in adults